- Raised $30M grant, May 2005
- Raised $25M funding round, Jan 2002
About
Formulex Pharma Innovations continues the activities of SoluBest Ltd in the field of nanotechnology-based drug delivery and formulation. Formulex generates innovative formulation solutions for Israeli and global clients in diversified fields such as biopharmaceuticals, nutraceuticals, and agrochemicals. The formulation development is accompanied by full analytical support and stability studies. Formulex has been developing more than 10 medical cannabis products using its patented Solumer and generic technologies. Five of the products are in the clinical and commercial stages. Solumer was developed by Solubest to maximize the solubility, bioavailability, and physical stability of drug substances utilizing sub-micron-particle engineering. The company designed solid dispersion formulations through a proprietary spray drying process. The technology is proven in preclinical and clinical trials to enhance bioavailability and drug substance performance. Formulex is able to develop and produce under GMP conditions oral, topical, and inhaled dosage forms for clinical phases one and two.
Funding history · 2 rounds · $55.0M total
Q&A
- What is Formulex Pharma Innovations' primary focus?
- Formulex Pharma Innovations specializes in nanotechnology-based drug delivery and formulation, providing innovative solutions for clients in biopharmaceuticals, nutraceuticals, and agrochemicals.
- How many employees does Formulex Pharma Innovations have?
- Formulex Pharma Innovations has 1-10 employees.
- What is the total amount of funding Formulex Pharma Innovations has raised?
- Formulex Pharma Innovations has raised a total of $55,000,000.
- When was Formulex Pharma Innovations founded?
- Formulex Pharma Innovations was founded in July 2001.
- Does Formulex Pharma Innovations have any patents?
- Yes, Formulex Pharma Innovations holds patents, including for its Solumer technology.
- What is the Solumer technology developed by Formulex Pharma Innovations?
- Solumer is a patented technology developed by Formulex Pharma Innovations (formerly SoluBest) to maximize the solubility, bioavailability, and physical stability of drug substances through sub-micron-particle engineering and proprietary spray drying processes.
- What types of products has Formulex Pharma Innovations developed using its technology?
- Formulex Pharma Innovations has developed over 10 medical cannabis products using its patented Solumer and generic technologies, with five products currently in clinical and commercial stages.
- What dosage forms can Formulex Pharma Innovations develop and produce?
- Formulex Pharma Innovations can develop and produce oral, topical, and inhaled dosage forms under GMP conditions for clinical phases one and two.
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | formulex-pi.com/ |
|---|---|
| linkedin.com/company/1044256 |
Identifiers & details
| Former names | SoluBest |
|---|---|
| Founded | 2001-7 |
| Employees (exact) | 5 |
Radar intelligence
Patents
| EPO | 3 |
|---|
Web history (Wayback)
| Domain | formulex-pi.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|